Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Synthesis and 11 beta hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group

Authors
Kwon, Sung WookKang, Seung KyuLee, Jae HongBok, Joo HwanKim, Chi HyunRhee, Sang DalJung, Won HoonKim, Hee YounBae, Myung AeSong, Jin SookHa, Duck ChanCheon, Hyae GyoungKim, Ki YoungAhn, Jin Hee
Issue Date
Jan-2011
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Keywords
Diabetes; 11beta-HSD1; Thiazolidine; Adamantyl
Citation
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.21, no.1, pp.435 - 439
Indexed
SCIE
SCOPUS
Journal Title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume
21
Number
1
Start Page
435
End Page
439
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/113329
DOI
10.1016/j.bmcl.2010.10.123
ISSN
0960-894X
Abstract
A new series of thiazolidine derivatives with an adamantyl group was synthesized and evaluated for their ability to inhibit 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1). Our initial compound 5a showed a weak inhibitory activity. Significant improvements in potency were achieved by substituent modification. The potent compound 8g (E) showed good in vitro inhibitory activity toward human 11 beta-HSD1, selectivity toward 11 beta-HSD2, metabolic stability, pharmacokinetic, and safety profile. Furthermore, this compound significantly inhibited 11 beta-HSD1 activity in rat and monkey models, and showed improved glycemic control in KKAy mice. (c) 2010 Elsevier Ltd. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Science > Department of Chemistry > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE